Cargando…
Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991251/ http://dx.doi.org/10.1186/2051-1426-1-S1-P272 |
| _version_ | 1782312401299832832 |
|---|---|
| author | Sabado, Rachel L Pavlick, Anna Gnjatic, Sacha Cruz, Crystal Vengco, Isabelita Hasan, Farah Darvishian, Farbod Chiriboga, Luis Holman, Rose Marie Escalon, Juliet Muren, Caroline Escano, Crystal Yepes, Ethel Sharpe, Dunbar Adams, Sylvia Ott, Patrick Jungbluth, Achim Pan, Linda Venhaus, Ralph Bhardwaj, Nina |
| author_facet | Sabado, Rachel L Pavlick, Anna Gnjatic, Sacha Cruz, Crystal Vengco, Isabelita Hasan, Farah Darvishian, Farbod Chiriboga, Luis Holman, Rose Marie Escalon, Juliet Muren, Caroline Escano, Crystal Yepes, Ethel Sharpe, Dunbar Adams, Sylvia Ott, Patrick Jungbluth, Achim Pan, Linda Venhaus, Ralph Bhardwaj, Nina |
| author_sort | Sabado, Rachel L |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3991251 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39912512014-05-05 Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma Sabado, Rachel L Pavlick, Anna Gnjatic, Sacha Cruz, Crystal Vengco, Isabelita Hasan, Farah Darvishian, Farbod Chiriboga, Luis Holman, Rose Marie Escalon, Juliet Muren, Caroline Escano, Crystal Yepes, Ethel Sharpe, Dunbar Adams, Sylvia Ott, Patrick Jungbluth, Achim Pan, Linda Venhaus, Ralph Bhardwaj, Nina J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3991251/ http://dx.doi.org/10.1186/2051-1426-1-S1-P272 Text en Copyright © 2013 Sabado et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Sabado, Rachel L Pavlick, Anna Gnjatic, Sacha Cruz, Crystal Vengco, Isabelita Hasan, Farah Darvishian, Farbod Chiriboga, Luis Holman, Rose Marie Escalon, Juliet Muren, Caroline Escano, Crystal Yepes, Ethel Sharpe, Dunbar Adams, Sylvia Ott, Patrick Jungbluth, Achim Pan, Linda Venhaus, Ralph Bhardwaj, Nina Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma |
| title | Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma |
| title_full | Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma |
| title_fullStr | Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma |
| title_full_unstemmed | Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma |
| title_short | Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma |
| title_sort | phase i/ii study of resiquimod as an immunologic adjuvant for ny-eso-1 protein vaccination in patients with melanoma |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991251/ http://dx.doi.org/10.1186/2051-1426-1-S1-P272 |
| work_keys_str_mv | AT sabadorachell phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma AT pavlickanna phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma AT gnjaticsacha phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma AT cruzcrystal phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma AT vengcoisabelita phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma AT hasanfarah phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma AT darvishianfarbod phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma AT chiribogaluis phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma AT holmanrosemarie phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma AT escalonjuliet phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma AT murencaroline phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma AT escanocrystal phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma AT yepesethel phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma AT sharpedunbar phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma AT adamssylvia phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma AT ottpatrick phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma AT jungbluthachim phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma AT panlinda phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma AT venhausralph phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma AT bhardwajnina phaseiiistudyofresiquimodasanimmunologicadjuvantfornyeso1proteinvaccinationinpatientswithmelanoma |